EUROAPI Increases the Resources Allocated to the Liquidity Contract With Kepler Cheuvreux
24 Outubro 2023 - 12:45PM
Business Wire
Regulatory News:
In accordance with the provisions of article 4 of AMF decision
no. 2021-01 of June 22, 2021, EUROAPI (Paris:EAPI) announced today
that it has increased the resources allocated to the liquidity
contract entrusted to Kepler Cheuvreux by 2 million euros (€
2,000,000.00).
Following the addition of these resources, the position on
October 24, 2023, is:
- 170,800 shares
- 2,263,204.73 euros
About EUROAPI
EUROAPI is focused on reinventing active ingredient solutions to
sustainably meet customers’ and patients’ needs around the world.
We are a leading player in active pharmaceutical ingredients with
approximately 200 products in our portfolio, offering a large span
of technologies while developing innovative molecules through our
Contract Development and Manufacturing Organization (CDMO)
activities.
Taking action for health by enabling access to essential
therapies inspires our 3,450 people every day. With strong research
and development capabilities and six manufacturing sites, all
located in Europe, EUROAPI ensures API manufacturing of the highest
quality to supply customers in more than 80 countries. EUROAPI is
listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI). Find
out more at www.euroapi.com and follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231024509728/en/
Media Relations Contact: Laurence Bollack Mob.: +33 (0)6
81 86 80 19 mr@euroapi.com
Investor Relations Contact: Sophie Palliez-Capian Mob.:
+33 (0)6 87 89 33 51 ir@euroapi.com
Euroapi (EU:EAPI)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Euroapi (EU:EAPI)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024